Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Were trying to improve peoples lives and make it so that they can feel better, function better, and do the things they want to do
Eli Lilly has just released the latest positive Phase III trial results of its experimental oral GLP-1 drug, orforglipron
There is no pharmacological rationale for cycling that can be cited from peer-reviewed literature
What is GLP-1 and Why Is It Important
Afamelanotides trial data describe a characterized implant delivered by clinicians not a self-injected research vial of a Melanotan-1 peptide, and certainly not Melanotan 2
The value share of assets with a novel MoA has risen sharply to 53 percent in 2025, up from 35 percent in 2024 (see Figure 6)
US$ 21.14
US$ 24.62
US$ 28.71
US$ 21.02
US$ 24.16
